
Stacey Nee Macfarlane
Examiner (ID: 8364, Phone: (571)270-3057 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1609, 1649, 1675 |
| Total Applications | 1032 |
| Issued Applications | 433 |
| Pending Applications | 132 |
| Abandoned Applications | 495 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17586556
[patent_doc_number] => 11324798
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Materials and methods for treatment of inflammation
[patent_app_type] => utility
[patent_app_number] => 16/986802
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 10701
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986802
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/986802 | Materials and methods for treatment of inflammation | Aug 5, 2020 | Issued |
Array
(
[id] => 16613666
[patent_doc_number] => 20210032319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => TAU IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/933792
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933792
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/933792 | Tau immunotherapy | Jul 19, 2020 | Issued |
Array
(
[id] => 17865340
[patent_doc_number] => 20220288075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => METHOD AND COMPOSITION FOR TREATING PAIN
[patent_app_type] => utility
[patent_app_number] => 17/625434
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625434
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625434 | METHOD AND COMPOSITION FOR TREATING PAIN | Jul 9, 2020 | Pending |
Array
(
[id] => 16391021
[patent_doc_number] => 20200331962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => NOVEL THERAPEUTIC USES OF MU-OPIATE RECEPTOR PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/921223
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921223
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/921223 | NOVEL THERAPEUTIC USES OF MU-OPIATE RECEPTOR PEPTIDES | Jul 5, 2020 | Abandoned |
Array
(
[id] => 17952481
[patent_doc_number] => 11478556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine
[patent_app_type] => utility
[patent_app_number] => 16/909896
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 44
[patent_no_of_words] => 20092
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909896
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/909896 | Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine | Jun 22, 2020 | Issued |
Array
(
[id] => 16345145
[patent_doc_number] => 20200309795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => DIAGNOSTIC BIOMARKER PROFILES FOR THE DETECTION AND DIAGNOSIS OF ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/902829
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902829
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902829 | DIAGNOSTIC BIOMARKER PROFILES FOR THE DETECTION AND DIAGNOSIS OF ALZHEIMER'S DISEASE | Jun 15, 2020 | Abandoned |
Array
(
[id] => 17928281
[patent_doc_number] => 20220323406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => METHODS AND COMPOSITIONS FOR DIFFERENTIATING STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/617048
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617048
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617048 | METHODS AND COMPOSITIONS FOR DIFFERENTIATING STEM CELLS | Jun 4, 2020 | Pending |
Array
(
[id] => 17881230
[patent_doc_number] => 20220296707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => ANTI-OPIOID COMPOUNDS AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/616031
[patent_app_country] => US
[patent_app_date] => 2020-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616031
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616031 | ANTI-OPIOID COMPOUNDS AND METHODS OF MAKING AND USING SAME | Jun 3, 2020 | Pending |
Array
(
[id] => 16420579
[patent_doc_number] => 20200345777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/891841
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24084
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/891841 | Immunotherapy against neuronal and brain tumors | Jun 2, 2020 | Issued |
Array
(
[id] => 19197290
[patent_doc_number] => 11994522
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Biomarker detection process and assay of neurological condition
[patent_app_type] => utility
[patent_app_number] => 16/890943
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 11416
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890943
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890943 | Biomarker detection process and assay of neurological condition | Jun 1, 2020 | Issued |
Array
(
[id] => 16345139
[patent_doc_number] => 20200309789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 16/890739
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890739 | BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS | Jun 1, 2020 | Abandoned |
Array
(
[id] => 17490622
[patent_doc_number] => 11279914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Assembly of functionally integrated human forebrain spheroids and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/884980
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 143
[patent_no_of_words] => 26415
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 339
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884980
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/884980 | Assembly of functionally integrated human forebrain spheroids and methods of use thereof | May 26, 2020 | Issued |
Array
(
[id] => 16512966
[patent_doc_number] => 20200392224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => METHODS FOR TREATING SYSTEMIC SCLEROSIS
[patent_app_type] => utility
[patent_app_number] => 16/881863
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881863
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/881863 | Methods for treating systemic sclerosis | May 21, 2020 | Issued |
Array
(
[id] => 16557576
[patent_doc_number] => 20210002724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Genome-Based Methods For Reducing Cardiovascular Risk
[patent_app_type] => utility
[patent_app_number] => 16/876030
[patent_app_country] => US
[patent_app_date] => 2020-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/876030 | Genome-based methods for reducing cardiovascular risk | May 15, 2020 | Issued |
Array
(
[id] => 17664164
[patent_doc_number] => 11357840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors
[patent_app_type] => utility
[patent_app_number] => 15/931081
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24246
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931081
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931081 | Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors | May 12, 2020 | Issued |
| 16/872064 | DETECTION OF DEBRIS IN RECIRCULATING PHAGOCYTES | May 10, 2020 | Abandoned |
Array
(
[id] => 16570659
[patent_doc_number] => 20210009665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => ANTIBODIES TO AMYLOID BETA
[patent_app_type] => utility
[patent_app_number] => 16/864439
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864439
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864439 | Antibodies to amyloid beta | Apr 30, 2020 | Issued |
Array
(
[id] => 17434800
[patent_doc_number] => 11260106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Compositions and methods for treatment of GCASE related disease states
[patent_app_type] => utility
[patent_app_number] => 16/860319
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 53
[patent_no_of_words] => 7920
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860319
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860319 | Compositions and methods for treatment of GCASE related disease states | Apr 27, 2020 | Issued |
Array
(
[id] => 17658467
[patent_doc_number] => 20220178932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => CANCER DETECTION METHOD AND DETECTION REAGENT
[patent_app_type] => utility
[patent_app_number] => 17/605327
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605327
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605327 | CANCER DETECTION METHOD AND DETECTION REAGENT | Apr 14, 2020 | Abandoned |
Array
(
[id] => 16361364
[patent_doc_number] => 20200318115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => GENE THERAPIES FOR LYSOSOMAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/838993
[patent_app_country] => US
[patent_app_date] => 2020-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16838993
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/838993 | Gene therapy for neurodegenerative disorders | Apr 1, 2020 | Issued |